Nanomedicines to Improve the Therapeutic Index of Drugs in Modern Drug Design Marianne Ashford, AstraZeneca, speaking at Nanomedicine 2014.
Using In vitro and In vivo Models to Assess the Local and Systemic Responses to Nanomaterial Exposure Vicki Stone, Heriot-Watt University, speaking at Nanomedicine 2014.
Improved Oral Delivery of Antiretroviral Drugs Via A Novel Synthesis of Solid Drug Nanoparticle Formulations Andrew Owen, University of Liverpool, speaking at Nanomedicine 2014.
Biodegradable and Biocompatible Comb-Like Polymers for Biomedical Applications Davide Moscatelli, Politecnico di Milano, speaking at Nanomedicine 2014.
Biotransformation: Still a Bottleneck for in Vitro Kinetic and Dynamic Approaches Sandra Coecke, European Centre for the Validation of Alternative Methods, speaking at ADME & Predictive Toxicology Europe
Technology Spotlight: microRNA Biomarkers in Biofluids: Challenges and Solutions Ditte Andreasen, Exiqon, speaking at Genomics Research Europe 2013.
Mapping Chemical Gradients in Living Tissue in Space and Time Using Microfluidics Charles Henry, Associate Professor, Colorado State University, speaking at Lab on a Chip World Congress 2013.
Drug-drug combinations made simple Roderick L. Beijersbergen, Associate Professor Division of Molecular Carcinogenesis and Head NKI Robotics and Screening Center.
Your body is 3D, why is your cell culture not? Christian Oberdanner, PhD, Application Specialist Sales & Marketing, Tecan Austria GmbH